Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Psoriatic arthritis looks different for each ... Salazar, meanwhile, says that pain from her spondylitis, or spinal ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...

The day that I had my first real psoriatic arthritis flare, I was getting up to go to work. I couldn't grip my pants well enough to pull them up. I couldn't get dressed. I couldn't move enough to ...

Discover how both heat and cold can impact psoriatic arthritis symptoms and learn which is best for your relief.

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Psoriatic arthritis (PsA ... of cervical spine are features that differentiate axial PsA from ankylosing spondylitis. Standardized assessment of damage to axial joints in PsA may be performed ...

Dr. Ruderman’s clinical focus is on Rheumatoid Arthritis, Psoriatic Arthritis (combined program with Dermatology), Spondyloarthritis. Dr. Gordon has received honoraria or research support from ...